Life ScienceCompany
Genzyme has acquired 17 companies of its own. A total of 9 acquisitions came from private equity firms. It has also divested 3 assets.
Genzyme’s largest acquisition to date was in 2004, when it acquired ILEX Oncology for $1.0B. It’s largest disclosed sale occurred in 2010, when it sold Genzyme Genetics to Laboratory of America Holdings for $925M. Genzyme has acquired in 8 different US states, and 4 countries. The Company’s most targeted sectors include life science (75%) and medical products (25%).
Join Mergr and gain access to Genzyme’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity15
- M&A Buy Activity12
- M&A Sell Activity3
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 12
- M&A Advisors 3
Unlimited Searches
